Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4455-4466

  Sangle, Ganesh V ^a   Zhao, Ruozhi ^a   Mizuno, Tooru M ^a   Shen, Garry X ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTIBODY; CATION; CYBA PROTEIN, HUMAN; DIPHENYLIODONIUM SALT; DNA BINDING PROTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED LIPOPROTEINS, LDL; HEAT SHOCK TRANSCRIPTION FACTOR; IMMUNOGLOBULIN RECEPTOR; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAF PROTEIN; RAS PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; TRANSCRIPTION FACTOR;

ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; NADPH OXIDASE; ONIUM COMPOUNDS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STREPTOZOCIN; TRANSCRIPTION FACTORS;

EID: 77956028829     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0323     Document Type: Article

References (60)

1. Reimann M, Bonifacio E, Solimena M, Schwarz PE, Ludwig B, Hanefeld M, Bornstein SR 2009 An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Ther 121:317-331
2. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ 2004 Trends in cardiovascular complications of diabetes. JAMA 292:2495-2499
3. Libby P, Theroux P 2005 Pathophysiology of coronary artery disease. Circulation 111:3481-3488
4. Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P 1989 Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin. Thromb Haemost 61:370-373
5. Aso Y 2007 Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci 12:2957-2966
6. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM 2005 Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15:16R-28R
7. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL 1989 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
8. Lyons TJ 1993 Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 71:26B-31B
9. Tames FJ, Mackness MI, Arrol S, Laing I, Durrington PN 1992 Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. Atherosclerosis 93:237-244
10. Zhang J, Ren S, Sun D, Shen GX 1998 Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler Thromb Vasc Biol 18:1140-1148
11. Ren S, Lee H, Hu L, Lu L, Shen GX 2002 Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells. J Clin Endocrinol Metab 87:286-291 (Pubitemid 34084703)
12. Zhao R, Shen GX 2007 Involvement of heat shock factor-1 in glycated LDL-induced upregulation of plasminogen activator inhibitor-1 in vascular endothelial cells. Diabetes 56:436-444
13. Morano KA, Thiele DJ 1999 Heat shock factor function and regulation in response to cellular stress, growth, and differentiation signals. Gene Expr 7:271-282
14. Sobel BE, Woodcock-Mitchell J, Schneider DJ, Holt RE, Marutsuka K, Gold H 1998 Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence. Circulation 97:2213-2221
15. Pandolfi A, Cetrullo D, Polishuck R, Alberta MM, Calafiore A, Pellegrini G, Vitacolonna E, Capani F, Consoli A 2001 Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 21:1378-1382
16. Zhao R, Shen GX 2005 Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL. Atherosclerosis 179:277-284
17. Yamamoto Y, Yamagishi S, Yonekura H, Doi T, Tsuji H, Kato I, Takasawa S, Okamoto H, Abedin J, Tanaka N, Sakurai S, Migita H, Unoki H, Wang H, Zenda T, Wu PS, Segawa Y, Higashide T, Kawasaki K, Yamamoto H 2000 Roles of the AGE-RAGE system in vascular injury in diabetes. Ann NY Acad Sci 902:163-170; discussion 170-172
18. Sangle GV, Zhao R, Shen GX 2008 Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells. Am J Physiol Endocrinol Metab 295:E1243-E1254
19. Takai Y, Sasaki T, Matozaki T 2001 GTP-binding proteins. Physiol Rev 81:153-208
20. Kowluru RA, Kowluru A, Chakrabarti S, Khan Z 2004 Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 53:775-783
21. Cuda G, Paternò R, Ceravolo R, Candigliota M, Perrotti N, Perticone F, Faniello MC, Schepis F, Ruocco A, Mele E, Cassano S, Bifulco M, Santillo M, Avvedimento EV 2002 Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation 105:968-974
22. Lander HM, Milbank AJ, Tauras JM, Hajjar DP, Hempstead BL, Schwartz GD, Kraemer RT, Mirza UA, Chait BT, Burk SC, Quilliam LA 1996 Redox regulation of cell signalling. Nature 381:380-381
23. Iwasaki H, Okamoto R, Kato S, Konishi K, Mizutani H, Yamada N, Isaka N, Nakano T, Ito M 2008 High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-κB activation in bovine aortic endothelial cells. Atherosclerosis 196:22-28
24. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM 1997 Activation of the receptor for advanced glycation end products triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810-17814 (Pubitemid 27311222)
25. Warne PH, Viciana PR, Downward J 1993 Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro Nature 364:352-355
26. Cheng TH, Shih NL, Chen SY, Loh SH, Cheng PY, Tsai CS, Liu SH, Wang DL, Chen JJ 2001 Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol 33:1805-1814
27. Griendling KK, Ushio-Fukai M 1997 NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 7:301-307
28. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL 2001 Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280:E685-E694 (Pubitemid 32466835)
29. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM 2002 Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656-1662
30. Duell PB, Oram JF, Bierman EL 1990 Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 39:1257-1263
31. Ren S, Shen GX 2000 Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells. Arterioscler Thromb Vasc Biol 20:1688-1693 (Pubitemid 30353906)
32. Antalis TM, Clark MA, Barnes T, Lehrbach PR, Devine PL, Schevzov G, Goss NH, Stephens RW, Tolstoshev P 1988 Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci USA 85:985-989
33. Ponte P, Ng SY, Engel J, Gunning P, Kedes L 1984 Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res 12:1687-1696
34. Krag S, Nyengaard JR, Wogensen L 2007 Combined effects of moderately elevated blood glucose and locally produced TGF-β1 on glomerular morphology and renal collagen production. Nephrol Dial Transplant 22:2485-2496
35. Ren S, Shatadal S, Shen GX 2000 Protein kinase C-β mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells. Am J Physiol Endocrinol Metab 278:E656-E662
36. Zhu Y, Liao H, Wang N, Ma KS, Verna LK, Shyy JY, Chien S, Stemerman MB 2001 LDL-activated p38 in endothelial cells is mediated by Ras. Arterioscler Thromb Vasc Biol 21:1159-1164 (Pubitemid 34215144)
37. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D 1982 Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 31:283-291
38. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A 1992 Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004
39. Isoda K, Folco E, Marwali MR, Ohsuzu F, Libby P 2008 Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis. Atherosclerosis 198:307-312
40. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A 1993 Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143:1699-1712
41. Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PW, Verma S 2006 C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48:504-511
42. Ruiz-Velasco N, Domínguez A, Vega MA 2004 Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-γ ligands Putative contribution of Rho GTPases in statin-induced CD36 expression. Biochem Pharmacol 67:303-313 (Pubitemid 38112761)
43. Zhang FL, Casey PJ 1996 Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241-269
44. Xu Q, Schett G, Li C, Hu Y, Wick G 2000 Mechanical stress-induced heat shock protein 70 expression in vascular smooth muscle cells is regulated by Rac and Ras small G proteins but not mitogen-activated protein kinases. Circ Res 86:1122-1128
45. Matsunaga T, Nakajima T, Miyazaki T, Koyama I, Hokari S, Inoue I, Kawai S, Shimomura H, Katayama S, Hara A, Komoda T 2003 Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cells. Metabolism 52:42-49
46. Zhao R, Ma X, Xie X, Shen GX 2009 Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Am J Physiol Endocrinol Metab 297:E104-E111
47. Gao X, Zhang H, Schmidt AM, Zhang C 2008 AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 295:H491-H498
48. Deora AA, Hajjar DP, Lander HM 2000 Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras. Biochemistry 39:9901-9908
49. Chen Y, Budd RC, Kelm Jr RJ, Sobel BE, Schneider DJ 2006 Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 26:1777-1783 (Pubitemid 44305331)
50. Rayappa S, Kowluru RA 2008 Role of Raf-1 kinase in diabetes-induced accelerated apoptosis of retinal capillary cells. Intern J of Biomed Sci 4:20-28
51. Zhao R, Ma X, Shen GX 2008 Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins. Mol Cell Biochem 317:197-204
52. Rikitake Y, Liao JK 2005 Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 111:3261-3268
53. Metzler B, Abia R, Ahmad M, Wernig F, Pachinger O, Hu Y, Xu Q 2003 Activation of heat shock transcription factor 1 in atherosclerosis. Am J Pathol 162:1669-1676 (Pubitemid 36512850)
54. Pirkkala L, Nykänen P, Sistonen L 2001 Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 15:1118-1131
55. Rocnik E, Chow LH, Pickering JG 2000 Heat shock protein 47 is expressed in fibrous regions of human atheroma and is regulated by growth factors and oxidized low-density lipoprotein. Circulation 101:1229-1233 (Pubitemid 30158607)
56. Toma L, Stancu CS, Botez GM, Sima AV, Simionescu M 2009 Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose. Biochem Biophys Res Commun 390:877-882
57. Ahn SG, Thiele DJ 2003 Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev 17:516-528
58. Sangle GV, Chowdhury SK, Xie X, Stelmack GL, Halayko AJ, Shen GX 2010 Impairment of mitochondrial respiratory chain activity in aortic endothelial cells induced by glycated low-density lipoprotein. Free Radic Biol Med 48:781-790
59. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ 2000 Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192:1001-1014
60. Madamanchi NR, Runge MS 2007 Mitochondrial dysfunction in atherosclerosis. Circ Res 100:460-473